Filing metadata

Accession number
0001209191-23-030581
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
May 18, 2023
Reporting period
May 16, 2023
Description
Insider transaction

Explore SEC Filings Hub